Table 3  Incidence and location of recurrence.

	UKE			CaRE-1
Location	Total (n = 21 pts.)	Pelvic N− (n = 15 pts.)	Pelvic N+ (n = 6 pts.)	Total (n = 70 pts.)	Pelvic N− (n = 43 pts.)	Pelvic N+ (n = 14 pts.)	Status unknown (n = 13 pts.)
pts. = patients
Number of recurrences	5 (23.8%)	2 (13.3%)	3 (50%)	30 (42.9%)	17 (39.5%)	8 (57.1%)	5 (38.5%)
No recurrence	16 (76.2%)	13 (86.6%)	3 (50%)	32 (45.7%)	22 (51.2%)	4 (28.6%)	6 (46.2%)
Vulva	2 (9.5%)	2 (13.3%)	0	15 (21.4%)	10 (23.3%)	3 (21.4%)	2 (15.4%)
Groin	1 (4.8%)	0	1 (16.6%)	1 (1.4%)	1 (2.3%)	0	0
Vulva + groin	0	0	0	3 (4.3%)	0	1 (7.1%)	2 (15.4%)
Pelvis (± other)	0	0	0	4 (5.7%)	3 (7%)	0	1 (7.7%)
Distant metastasis (± other)	2 (9.4%)	0	2 (33.3%)	7 (10%)	3 (7%)	4 (28.6%)	0